Clinical Trial Update: A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control

View source ↗

Summary

A completed postmarketing study comparing cardiovascular risks in women using ORTHO EVRA vs traditional oral contraceptives, focusing on venous thromboembolism,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Stroke
• Venous Thromboembolism

Drugs mentioned

• ORTHO EVRA (ethinyl estradiol / norelgestromin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Contraception, Female Contraception | Status: COMPLETED